GILLIAN ATHEY: Open Payments
NPI 1285062307 · ROCKVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,167 in 134 payments from 21 companies in 2025. Trend: 2023 $4,860 · 2024 $3,813 · 2025 $3,167
Food & beverage: $3,161Education: $7
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 13 | $330 |
| Galderma Laboratories, L.P. | 15 | $242 |
| Organon LLC | 11 | $241 |
| GENZYME CORPORATION | 5 | $233 |
| LEO Pharma Inc. | 8 | $228 |
| Incyte Corporation | 8 | $224 |
| ABBVIE INC. | 14 | $210 |
| Arcutis Biotherapeutics, Inc. | 7 | $205 |
| Novartis Pharmaceuticals Corporation | 10 | $190 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $177 |
Products named: DUPIXENT, CIBINQO, ADBRY, OPZELURA, Zoryve, COSENTYX, NEMLUVIO, SOFDRA.
Industry payments across MD — which companies pay providers there.
